• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number ETUF3214C102E
Device Problems Difficult to Remove (1528); Separation Failure (2547)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/15/2014
Event Type  malfunction  
Event Description
An endurant ii stent graft system was implanted for the endovascular treatment of a 65mm diameter and 120mm in length abdominal aortic aneurysm.The proximal neck was 25 mm in diameter and 20 mm in length.The proximal neck had moderate calcification.The right iliac was severely calcified, and the left iliac was moderately calcified.It was reported that while bringing the nose cone back through the graft, the nose cone caught on the suprarenal stent.The anchoring pins of the suprarenal stent then became entangled.The nose cone was successfully withdrawn.An unsuccessful attempt was made to correct the entanglement with a reliant balloon.There is no endoleak and the stent seems to be against the aortic wall.The physician does not think that the stents are sticking into the aorta because we were able to pass an inflated reliant past the stent without any deformation of the balloon or stent.No clinical sequelae were reported and the patient is fine.A review of a single returned still angiogram image at implant confirmed that 2 or 3 of the suprarenal stents appeared entangled at their pins.The proximal markers were also not in the same plane.The cause of the entanglement could not be determined.
 
Manufacturer Narrative
(b)(4).Evaluation, conclusion: (unknown cause of event).(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC CARDIOVASCULAR
3576 unocal place
santa rosa CA 95403
Manufacturer Contact
ludmila voulfson
3576 unocal place
santa rosa, CA 95403
7075661229
MDR Report Key3863863
MDR Text Key4570138
Report Number2953200-2014-01162
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/15/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/10/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/06/2015
Device Catalogue NumberETUF3214C102E
Device Lot NumberV04112541
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/15/2014
Date Device Manufactured09/06/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age00084 YR
-
-